In California, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, used the gene-editing tool, CRISPR, to reprogram mutated rod photoreceptors and restoring vision in two mouse models. Retinitis pigmentosa is an inherited vision disorder resulting from genetic mutation in more than 60 genes making it difficult for night vision, peripheral vision, color discernment and central vision. It affects about 1 in 4,000 people globally with the eventual result possibly becoming legal blindness and there is no current treatment for it. The ability of researchers to shut off or deactivate certain gene “switches” allowed them to modify select genes to restore vision. They hope to perform clinical trials on humans soon since there is no other treatment or cure for retinitis pigmentosa currently.
Latest article
À_SOMBRA mycelium burial urn embraces ecological regeneration
In Brazil, the À_SOMBRA project has added a new eco-friendly end-of-life option. Designed by João Pedro Alves Cavalcanti and Jeanine Torres Geammal from the...
Shadow puppet art exhibit swaps animal leather for kombucha byproduct
In India, kombucha byproduct is being used to produce sustainable leather for shadow puppet exhibit Luminous Lore.
The exhibit aims to showcase Tholu Bommalata,...
Save the sturgeon with Umami Bioworks cultivated caviar
In Singapore, Umami Bioworks has unveiled cultivated caviar made from a mix of cultured sturgeon cells and plant-based ingredients.
The caviar alternative addresses many...